Kion Product of the Week: Kion Immune Maintaining year-round health requires more than just handwashing and a balanced diet
Alkonyi I, Sandor A
Achieved IgG reduction is similar to that achieved by nipocalimab in human FcRn transgenic mice [360], and a concomitant therapeutic effect has been observed in animal models of arthritis, ITP and glomerulonephritis [414,415,416] and in clinical trials assessing safety (NCT01802697), increasing transplant success by negating pre-existing immunity (NCT02224820, NCT02426684, and NCT02475551), and in thrombotic thrombocytopenic purpura (NCT02854059)
Similar results were found in terms of function and by the 12 month follow up mark almost 80% of patients in the shockwave group were happy with their outcome compared to less than 40% in the control group
Shang et al., 2024) both show that intervention during this window can measurably shift outcomes more retrieved eggs, better embryo grades, higher pregnancy rates
The established maximum doses represent the upper limits studied in clinical trials, beyond which risk-benefit ratios become unfavorable
